Dave Moore in

Dave Moore

Login to view DISC.
Executive Vice President US Operations and Business Development and President Novo Nordisk Inc. at Novo Nordisk
📍 Plainsboro, New Jersey, United States

As Executive Vice President of US Operations and President of Novo Nordisk Inc. , he leads the companys mission to drive change for patients with chronic diseases. His career is marked by a focus on strategic growth, innovation, and harnessing the companys scientific power. He holds an MBA from Lehigh University.

His professional interests extend into policy, having completed a program in Health Policy Excellence at Jefferson Health. Public biographies note a passion for developing talent and fostering an inclusive, high-performance culture within his teams, highlighting a commitment to mentorship and leadership beyond business metrics.

Unique fact: He previously served as a Partner at Gurnet Point Capital, a healthcare investment fund, giving him a distinct venture capital perspective.

Read the full overview →
Experience
12 Years
Current Role
Executive Vice President US Operations and Business Development and President Novo Nordisk Inc.
Job Level
Leadership
Location
Plainsboro, New Jersey, United States
Personality Overview

How Dave shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Dave cares about

Biotech Partnerships
Actively pursuing and announcing licensing agreements with biotech firms like Lexicon, Gensaic, and United Biotechnology to pioneer new treatments for cardiometabolic diseases.
Obesity Treatment
Overseeing the development and commercialization of new solutions for obesity and type 2 diabetes, a core focus of Novo Nordisk's current strategy and recent announcements.
+5 more topics Login to view topics
Career

Work history

1-2025
Executive Vice President US Operations and Business Development and President Novo Nordisk Inc.
Novo Nordisk
3-2023 - 1-2025
Executive Vice President Corporate Development
Novo Nordisk
9-2022 - 3-2023
Senior Vice President of Corporate Development
Novo Nordisk
3-2020 - 9-2022
Partner
Gurnet Point Capital
5-2019 - 3-2020
Vant CEO
Roivant Sciences
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2009 - 2011
Health Policy Excellence
Jefferson Health
MBA
Lehigh University College of Business
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Novo Nordisk Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Dave. Free, 10 seconds.